| Popis: |
Hypothalamic axis deregulation is associated with clinical severity and depression in chronic heart failure (CHF). We investigated the relationship of serum prolactin, an indicator of hypothalamic axis function, to neurohomonal/immune activation and depressive symptoms in CHF as well as its prognostic value. Serum prolactin was determined in 180 patients with advanced CHF (aged 65 12 years, mean LVEF 27 7) along with natriuretic peptides (BNP), inflammatory cytokines, endothelial adhesion molecules, 6 min walk test (6MWT), and the Zung self-rating depression scale (SDS). Patients were followed for all-cause death or hospitalization for cardiovascular reasons for up to 8 months. Prolactin levels were significantly correlated with NYHA class (r 0.394, P 0.001), LVEF (r 0.314, P 0.001), 6MWT (r 0.353, P 0.001), BNP (r 0.374, P 0.001), Zung SDS (r 0.544, P 0.001), interleukin-6 (IL-6) (r 0.451, P 0.001), IL-10 (r 0.426, P 0.001), tumour necrosis factor (TNF)- (r 0.310, P 0.001), soluble Fas (r 0.333, P 0.001), soluble Fas-ligand (r 0.517, P 0.001), soluble intercellular adhesion molecule-1 (ICAM-1) (r 0.409, P 0.001), and soluble vascular cell adhesion molecule-1 (VCAM-1) (r 0.480, P 0.001). During follow-up, 119 patients (66) died or were hospitalized for cardiovascular events after a median time of 72 days (range 5220 days); these patients had higher baseline prolactin levels (10.2 5.7 vs. 6.7 4.3 ng/mL, P 0.001), and a prolactin value 4.5 ng/mL was associated with a higher rate of death or hospitalization (116 7 vs. 181 11 days, P 0.0001). In multivariate analysis, prolactin levels remained an independent predictor of death or hospitalization (4.5 vs. 4.5 ng/mL; odds ratio, 0.368; 95 confidence interval 0.1480.913; P 0.031), along with BNP (P 0.001) and 6MWT (P 0.020). Serum prolactin is associated with neurohormonal/immune activation and depressive symptoms and is an independent predictor of prognosis in advanced CHF. |
